Chronic Myelogenous Leukemia (CML) in the elderly.
作者信息
Balducci Lodovico, Dolan Dawn
机构信息
H. Lee Moffitt Cancer Center and Research Institute. 12902 Magnolia Dr, Tampa, Florida 33612.
出版信息
Mediterr J Hematol Infect Dis. 2014 Jun 1;6(1):e2014037. doi: 10.4084/MJHID.2014.037. eCollection 2014.
Abstract
摘要
相似文献
1
Chronic Myelogenous Leukemia (CML) in the elderly.老年慢性粒细胞白血病
Mediterr J Hematol Infect Dis. 2014 Jun 1;6(1):e2014037. doi: 10.4084/MJHID.2014.037. eCollection 2014.
2
Graft-versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia (BC-CML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared mechanisms of T cell killing, but programmed death ligands render CP-CML and not BC-CML GVL resistant.移植物抗白血病（GVL）对小鼠急变期慢性髓性白血病（BC-CML）和慢性期慢性髓性白血病（CP-CML）：T 细胞杀伤的共同机制，但程序性死亡配体使 CP-CML 而非 BC-CML 具有 GVL 抗性。
J Immunol. 2011 Aug 15;187(4):1653-63. doi: 10.4049/jimmunol.1100311. Epub 2011 Jul 18.
3
Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.骨髓性白血病患者的特异性皮肤浸润：一项对26例患者的临床病理研究及诊断标准评估
J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):966-78. doi: 10.1016/s0190-9622(99)70086-1.
4
5
Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.慢性粒细胞白血病患者中慢性淋巴细胞白血病的发生情况。
Indian J Pathol Microbiol. 2013 Jul-Sep;56(3):188-9. doi: 10.4103/0377-4929.120357.
6
Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.混合表型（T/B/髓系）髓外原始细胞危象作为慢性髓性白血病的初始表现。
Exp Mol Pathol. 2018 Apr;104(2):130-133. doi: 10.1016/j.yexmp.2018.02.005. Epub 2018 Mar 1.
7
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
8
9
10
Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.慢性髓性白血病的白血病前期：7 例病例的形态学和免疫组织化学特征。
Ann Diagn Pathol. 2016 Apr;21:53-8. doi: 10.1016/j.anndiagpath.2015.12.004. Epub 2016 Feb 6.
引用本文的文献
1
Imatinib Adherence and Persistence in Patients with Chronic Myeloid Leukemia in Belgium: Evidence from Real-World Data.比利时慢性髓性白血病患者的伊马替尼依从性和持续性：来自真实世界数据的证据
Patient Prefer Adherence. 2024 Sep 25;18:1991-2006. doi: 10.2147/PPA.S472478. eCollection 2024.
2
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study.老年 CML：共病和 TKI 选择对真实世界多中心研究的影响。
Ann Hematol. 2024 Sep;103(9):3585-3594. doi: 10.1007/s00277-024-05828-3. Epub 2024 Jun 11.
3
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.尼洛替尼作为临床试验之外的老年（>65 岁）慢性髓性白血病患者一线治疗的疗效和安全性。
Ann Hematol. 2023 Jun;102(6):1375-1382. doi: 10.1007/s00277-023-05159-9. Epub 2023 Apr 20.
4
CML in Elderly: Does Age Matter?老年慢性粒细胞白血病：年龄重要吗？
Indian J Hematol Blood Transfus. 2020 Jan;36(1):47-50. doi: 10.1007/s12288-019-01143-4. Epub 2019 Jun 6.
5
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.伊马替尼与多药联合治疗老年慢性髓性白血病患者：对缓解率、毒性和预后的影响
Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.
本文引用的文献
1
Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation.供体年龄会对脂肪组织来源的间充质干细胞的扩增和分化产生负面影响。
J Transl Med. 2014 Jan 7;12:8. doi: 10.1186/1479-5876-12-8.
2
Longitudinal changes in leukocyte telomere length and mortality in humans.人类白细胞端粒长度与死亡率的纵向变化。
J Gerontol A Biol Sci Med Sci. 2014 Feb;69(2):231-9. doi: 10.1093/gerona/glt153. Epub 2013 Oct 22.
3
Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults.简单的基于生物学的两种血清细胞因子炎症指数可预测老年人 10 年全因死亡率。
J Gerontol A Biol Sci Med Sci. 2014 Feb;69(2):165-73. doi: 10.1093/gerona/glt023. Epub 2013 May 20.
4
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.伊马替尼治疗高龄慢性髓性白血病慢性期患者：一项回顾性研究。
Drugs Aging. 2013 Aug;30(8):629-37. doi: 10.1007/s40266-013-0088-6.
5
Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.慢性髓性白血病患者全因死亡率趋势：监测、流行病学和最终结果数据库分析。
Cancer. 2013 Jul 15;119(14):2620-9. doi: 10.1002/cncr.28106. Epub 2013 Apr 26.
6
Senior adult oncology.老年肿瘤学
J Natl Compr Canc Netw. 2012 Feb;10(2):162-209. doi: 10.6004/jnccn.2012.0019.
7
Educational session: managing chronic myeloid leukemia as a chronic disease.教育课程：慢性髓性白血病的慢性病管理。
Hematology Am Soc Hematol Educ Program. 2011;2011:128-35. doi: 10.1182/asheducation-2011.1.128.
8
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008.慢性髓性白血病靶向治疗的成功案例：1973 年至 2008 年在瑞典诊断的患者的基于人群的研究。
J Clin Oncol. 2011 Jun 20;29(18):2514-20. doi: 10.1200/JCO.2011.34.7146. Epub 2011 May 16.
9
Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.年龄对甲磺酸伊马替尼治疗费城染色体阳性慢性粒细胞白血病患者预后的影响。
Cancer. 2003 Sep 15;98(6):1105-13. doi: 10.1002/cncr.11629.
Zotero 插件